Pfizer
PFE
2,805 hedge funds and large institutions have $160B invested in Pfizer in 2021 Q3 according to their latest regulatory filings, with 193 funds opening new positions, 1,221 increasing their positions, 1,117 reducing their positions, and 88 closing their positions.
119% more first-time investments, than exits
New positions opened: 193 | Existing positions closed: 88
52% more funds holding in top 10
Funds holding in top 10: 69 → 105 (+36)
11% more call options, than puts
Call options by funds: $3.5B | Put options by funds: $3.16B
10% more capital invested
Capital invested by funds: $146B → $160B (+$14.6B)
3% more funds holding
Funds holding: 2,734 → 2,805 (+71)
9% more repeat investments, than reductions
Existing positions increased: 1,221 | Existing positions reduced: 1,117
0.06% less ownership
Funds ownership: 66.46% → 66.4% (-0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$660M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$455M |
| 3 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
+$366M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$339M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$255M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$920M |
| 2 |
Sanders Capital
West Palm Beach,
Florida
|
-$651M |
| 3 |
Two Sigma Advisers
New York
|
-$433M |
| 4 |
JP Morgan Chase
New York
|
-$346M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$287M |
PFE Hedge Fund Activity: Q3 2021 in Review
2,805 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2021, worth a combined $160B — up 10% from $146B a quarter earlier.
Buyers outnumbered sellers: 193 funds opened new PFE positions and 88 closed out — a net gain of 105 holders — while 1,221 added to existing stakes and 1,117 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $660M. The largest seller was Wellington Management Group, cutting an estimated $920M.
- 2,805 institutional investors held Pfizer (PFE) as of Q3 2021, up from 2,734 in Q2 2021.
- Funds reported $160B of Pfizer stock for Q3 2021, up 10% quarter-over-quarter.
- 193 funds opened new Pfizer positions in Q3 2021 and 88 closed out, a net change of +105 holders.
- The largest Pfizer buyer in Q3 2021 was T. Rowe Price Associates, an estimated $660M added.
- The largest Pfizer seller in Q3 2021 was Wellington Management Group, an estimated $920M sold.
Based on aggregated 13F filings for Q3 2021.